| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 2.193 | 12.103 | 14.679 | 32.428 | 44.814 |
| Total Income - EUR | - | - | - | - | - | 2.193 | 12.103 | 14.679 | 32.428 | 44.821 |
| Total Expenses - EUR | - | - | - | - | - | 4.759 | 14.603 | 22.036 | 23.800 | 32.959 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -2.565 | -2.500 | -7.357 | 8.628 | 11.862 |
| Net Profit/Loss - EUR | - | - | - | - | - | -2.631 | -2.737 | -7.504 | 8.303 | 11.423 |
| Employees | - | - | - | - | - | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dysofrey S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 325.969 | 395.619 | 384.088 | 370.204 | 355.487 |
| Current Assets | - | - | - | - | - | 98 | 3.620 | 3.611 | 3.992 | -400 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 3.451 | 2.215 | -127 | -4.162 |
| Cash | - | - | - | - | - | 98 | 170 | 1.396 | 4.119 | 3.763 |
| Shareholders Funds | - | - | - | - | - | -2.590 | -5.269 | -12.789 | -4.447 | 7.000 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 328.656 | 404.509 | 400.489 | 378.643 | 348.087 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Dysofrey S.r.l.